HDAC-IN-4

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

HDAC-IN-4 

HDAC-IN-4 是一种选择性的 HDAC6 和 HDAC10 抑制剂，在 BRET 实验中，对 HDAC6 和 HDAC10 的 pIC50 分别为 7.2 和 6.8。具有抗肿瘤活性。

HDAC-IN-4

HDAC-IN-4 Chemical Structure

CAS No. : 1252003-13-6

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor with pIC50s of 7.2 and 6.8 in BRET assay, respectively. Antitumoral activity[1].

IC50 & Target

pIC50: 7.2 (HDAC6), and 6.8 (HDAC10)[1]
体外研究
(In Vitro)

HDAC-IN-4 inhibits HDAC1, HDAC2, HDAC3, HDAC8 and HDAC10 with pIC50s of 5.5, 4.6, 5.4, 5.4, 6.7 in FRET assay, respectively[1].
HDAC-IN-4 is more potent against HDAC6 than Tubastatin A, suggests that HDAC-IN-4 may be a better HDAC6 probe than Tubastatin A[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

335.40

Formula

C20H21N3O2
CAS 号

1252003-13-6
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Géraldy M, et al. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated. J Med Chem. 2019 May 9;62(9):4426-4443.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务